Skip to main content
. 2015 Jan 28;2015:413897. doi: 10.1155/2015/413897

Figure 2.

Figure 2

Cox proportional-hazards regression analyses of IMP3-positive and IMP3-negative HGGs for overall ((a), (c), and (e)) or disease-free survival ((b), (d), and (f)). IMP3 presence is a poor prognostic factor either considering high-grade gliomas (P = 0.0002, HR: 0.3392, 95% CI: 0.1928–0.5965 and P = 0.006, HR: 0.4586, 95% CI: 0.2631 to 0.7994 for OS and DFS, resp.) or separately grade III (P = 0.02, HR: 4.47, 95% CI: 1.19–16.8 and P = 0.02, HR: 13.30, 95% CI: 1.44–122.6 for OS and DFS, resp.) and GBM (P = 0.01, HR: 0.41, 95% CI: 0.19 to 0.84 and P = 0.04, HR: 0.5, 95% CI: 0.23–0.98 for OS and DFS, resp.) patients.